Analysis originally distributed on June 28, 2018 By: Michael Vodicka of Cannabis Stock Trades
October 30, 2017 was one of the best days of the year for the young cannabis industry.
That’s the date when Constellation Brands (STZ), the second-largest US beer maker, announced a 10% stake in Canopy Growth Corp. (CGC/WEED), the largest Canadian cannabis company.
It was a groundbreaking moment for the cannabis industry because it was the first time that a big alcohol company had invested directly in a cannabis company.
Not only did it give the young cannabis industry tons of credibility, it also sets the stage for big alcohol to invest billions into the cannabis industry in the next few years.
In the short run, Canopy shares jumped more than 23% in one day on the news.
In the long run, it triggered a 10-week rally in Canopy – and the entire cannabis sector – that sent shares deep into a new all-time high. Take a look. Continue reading "Molson Coors Eyeing Canadian Cannabis Partner"
Analysis originally distributed on June 21, 2018 By: Michael Vodicka of Cannabis Stock Trades
Germany has quickly emerged as one of the fastest-growing medical cannabis markets in the world.
According to a study on the German health insurance market, 500 German patients requested medical cannabis in January of 2017.
In December of the same year, the number of patients requesting reimbursements for cannabis prescriptions skyrocketed to 13,000.
What was the biggest factor that drove the huge spike?
German insurance companies started covering medical cannabis subscriptions in 2017 – and the number of patients surged.
Looking forward – this bullish trend is expected to accelerate.
Tens of thousands of new patients are expected to enroll in Germany’s medical cannabis program in 2018.
Longer term – I expect the success of Germany’s medical cannabis market to usher in recreational legalization. Continue reading "A New Entry Into Germany’s Cannabis Industry"
Analysis originally distributed on November 23, 2016 By: Michael Vodicka of Cannabis Stock Trades
If anyone thought investing in weed stock was going to be easy, this week was a reality check.
Cannabis stocks collided with two obstacles in the last week.
The first, four of the largest Canadian medical marijuana stocks were temporarily halted because of high levels of volatility.
For example, last Wednesday Canopy Growth Corp (CGC) was surging into a new all-time high above $17 – up more than 20% on the day.
While that was great news for shareholders, it set off the Toronto Stock Exchanges (TSE) circuit breaker. Shares were temporarily halted so the exchange engines wouldn’t melt down like a hunk of warm cheese.
Aphria (APH), the second-largest Canadian medical marijuana company, and Organigram (OGI), the third-largest Canadian medical marijuana company, were also halted last week after hitting new all-time highs.
The trading halts only lasted a few minutes at a time.
However, damage was inflicted. Continue reading "Cannabis Stocks Flashing Buy After Worst Week Of Year"